Answer
Nivolumab (OPDIVO) concentrate for solution for infusion is contraindicated in patients with hypersensitivity to nivolumab or any excipient listed in section 6.1 of its Summary of Product Characteristics.
Sources for this answer
- OPDIVO 10 mg/mL concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.3 Contraindications · Version 70Document updated
Sources checked